BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2023 4:15:34 AM | Browse: 253 | Download: 635
 |
Received |
|
2023-06-28 22:49 |
|
Peer-Review Started |
|
2023-06-28 22:51 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-06 08:46 |
|
Revised |
|
2023-08-06 16:08 |
|
Second Decision |
|
2023-09-12 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-09-12 07:06 |
|
Articles in Press |
|
2023-09-12 07:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-09-06 02:06 |
|
Typeset the Manuscript |
|
2023-09-15 07:58 |
|
Publish the Manuscript Online |
|
2023-09-20 04:15 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nedelcho Ivanov, Boris Krastev, Dimitrina Georgieva Miteva, Hristiana Batselova, Radostina Alexandrova and Tsvetelina Velikova |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| European Union-Next Generation EU, through the National Recovery and Resilience Plan of the Republic of Bulgaria |
BG-RRP-2.004-0008 |
|
| Corresponding Author |
Nedelcho Ivanov, FRCS (Hon), MD, PhD, Assistant Professor, Department of Clinical Immunology with Stem Cell Bank, University Hospital Alexanrovska, St. Georfi Sofiiski 1 str, Sofia 1431, Bulgaria. nedelcho.ivanov93@gmail.com |
| Key Words |
COVID-19; COVID-19 vaccines; RNA vaccines; Cancer; Oncological; Safety; Efficacy; Immunogenicity |
| Core Tip |
The coronavirus disease 2019 (COVID-19) pandemic has greatly impacted the lives of cancer patients. Their medical care has been challenging, given the competing risks of death from cancer and serious complications from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cancer patients are at high risk of severe complications and death from COVID-19. Protective SARS-CoV-2 antibodies and cellular immune response are induced after infection or/and COVID-19 vaccination. Vaccines decrease the risk of hospitalization and death from COVID-19. Therefore, vaccination of specific vulnerable groups, such as oncological patients, and all people in general, will slow the virus spread and save lives. |
| Publish Date |
2023-09-20 04:15 |
| Citation |
Ivanov N, Krastev B, Miteva DG, Batselova H, Alexandrova R, Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art. World J Clin Oncol 2023; 14(9): 343-356 |
| URL |
https://www.wjgnet.com/2218-4333/full/v14/i9/343.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v14.i9.343 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
